We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking QGEN? Get live short interest, options flow, and signals on ORTEX.Sign up free →
QG

Qiagen N.V. (QGEN) short interest & options flow

NYSE

QGEN closed at $50.22 on Friday, flat on the week, while its closest peers gained a median of 2.7% over the same period, a gap that reflects how thoroughly the EQT-led consortium's €9.7 billion bid has replaced the operating story. The analyst community is adjusting to that reality in real time. Barclays' Luke Sergott downgraded to Equal-Weight from Overweight on October 28…

Latest pulse28 Oct 2026

QGEN Barclays downgrade: Equal-Weight from Overweight, target cut to $53 from $55.

$50.38+0.06% 1d+0.42% 1w+12.58% 1mClose: 3 Nov 2026
Short interest % of float
Dropping
Live SI on ORTEX →
Cost to borrow
Low and dropping
Live CTB on ORTEX →
Availability
Rising
Live availability on ORTEX →
Market cap
$10.42B
Next earnings
4 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 4 Nov 2026

ORTEX chart of Qiagen N.V. (QGEN) share price and short interest (% of free float), six months to November 3, 2026

Latest signals on QGEN

  • Analyst

    QGEN Barclays downgrade: Equal-Weight from Overweight, target cut to $53 from $55.

    3 Analyst updates in 30 days

QGEN news and analysis

RSS

No long-form analysis yet for QGEN. Pulse alerts and the live data picture are available on ORTEX.

Open QGEN on ORTEX →

Want the live picture for QGEN?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for QGEN — free to start on ORTEX.

Sign up for free →Open QGEN on ORTEX